Bellus Labs, a New Jersey-based private label and custom formulation laboratory, is celebrating a decade of sustained growth. Founded in 2015 by chemist and CEO Kristina Cimo and her husband, Michael, ...

Ashely Claudino is an Evergreen Staff Writer from Portugal. She has a Translation degree from the University of Lisbon (2020, Faculty of Arts and Humanities). Nowadays, she mostly writes Fortnite and ...

After GSK’s $2 billion buyout of Canada-based Bellus Health last summer, an undisclosed number of the biotech’s team members are out of a job. “When two companies come together during an acquisition, ...

This arrangement was approved by the shareholders at BELLUS on June 16, 2023, according to a company press release. GSK announced on June 28, 2023 that it has completed the acquisition of BELLUS ...

Bellus Health Inc. shareholders have voted in favour of GSK PLC’s US$2-billion takeover of the Laval, Que.-based cough-treatment developer. This week Novartis AG said it would buy Seattle ...

Bellus' lead therapy, camlipixant, is being tested against refractory chronic cough. The company is a clinical-stage biotech with no marketed therapies. Bellus finished 2022 with $337.1 million. The ...

Bellus Health BLU and GSK plc GSK announced that the former got an offer to be acquired by the latter for $14.75 per share of common stock in cash, representing an approximate total equity value of $2 ...

GSK has said it will acquire Bellus Health for approximately $2bn in a deal that is set to expand the British drugmaker’s specialty medicines and respiratory pipeline. The acquisition will grant GSK ...

GSK Plc agreed to buy Canadian biotech Bellus Health Inc. for about $2 billion to bolster its pipeline of experimental medicines. The UK drugmaker will pay $14.75 per share in cash for Bellus, a 103% ...

April 18 (Reuters) - GSK (GSK.L), opens new tab plans to buy Canada-based drug developer Bellus Health Inc (BLU.TO), opens new tab in an all-cash deal for $2 billion as the British drugmaker expands ...